It has been clearly established that patients with cancer have an increased risk of venous thromboembolism (VTE) compared with patients without cancer. Venous thromboembolism, comprising deep vein ...

Incidence of venous thromboembolism remains "substantial" despite expert guidelines and ne ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Both trials used an open-label study design, the same target ...

BERLIN, GERMANY — Treatment of venous thromboembolism (VTE) varies widely, reflecting the broad heterogeneity among patients and underlining the need for individualized therapy, a new observational ...

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

Patients with cancer are increasingly at risk for venous thromboembolism (VTE). Rates of VTE, however, vary markedly among patients with cancer. This review focuses on recent data derived from ...

At the dawn of the 21st century, venous thromboembolism (VTE) treatment remained in the dark ages. Backed by an MD and a legacy of paternalistic practice, we convinced patients to do what now seems ...

Venous thromboembolism rates among patients with advanced non-small cell lung cancer varied by treatment type, according to retrospective study results. Patients treated with platinum-based ...

Each year, there are approximately 10 million cases of venous thromboembolism (VTE) worldwide. VTE, the formation of blood clots in the vein, is a dangerous and potentially deadly medical condition ...

The American College of Chest Physicians has released its latest guideline The American College of Chest Physicians has released the latest evidence-based guidelines, with updated recommendations, for ...

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Venous Thromboembolism Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's ...